[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:premalignant-lesion":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":37,"states":38},"Premalignant Lesion",4,2,[8,16,22,30],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06561087","Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions",[12],"Phase 2","RECRUITING","2026-08-26T02:16:45.157238Z","2026-05-05T02:43:27.258472Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05451303","Detection of Oral and Throat Cancers Using OralViome Cancer Testing System",[],"2026-08-26T02:18:43.501109Z","2026-05-13T02:55:06.349144Z",{"nct_id":23,"title":24,"phases":25,"status":27,"updated_at":28,"content_modified":29},"NCT07631013","Phase 1 Study Of TROP2 CAR\u002FIL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant Lesions",[26],"Phase 1","NOT_YET_RECRUITING","2026-08-26T02:16:46.951087Z","2026-06-06T00:48:49.541195Z",{"nct_id":31,"title":32,"phases":33,"status":34,"updated_at":35,"content_modified":36},"NCT03881098","The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy",[],"ACTIVE_NOT_RECRUITING","2026-08-03T02:54:15.542480Z","2026-05-05T02:43:27.265198Z",[],[]]